4th Quarter - Report

GEPHARDT GROUP GOVERNMENT AFFAIRS for BLUESPARK TECHNOLOGIES, INC.

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

FDA approval of technology

LobbyistCovered position, as disclosed
AMANDA ARMISTEAD —
THOMAS BLANK —
RICHARD GEPHARDT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Science/Technology SCI

FDA approval of technology

LobbyistCovered position, as disclosed
AMANDA ARMISTEAD —
THOMAS BLANK —
RICHARD GEPHARDT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

FDA approval of technology

LobbyistCovered position, as disclosed
AMANDA ARMISTEAD —
THOMAS BLANK —
RICHARD GEPHARDT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Homeland Security HOM

FDA approval of technology

LobbyistCovered position, as disclosed
AMANDA ARMISTEAD —
THOMAS BLANK —
RICHARD GEPHARDT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.